Randomized pilot trial of vitamin k2 for bone loss in patients with primary biliary cirrhosis [4]

Journal of Hepatology

Volumn 35, Issue 4, 2001, Pages 543-545

  Nishiguchi, Shuhei ^a   Shimoi, Susumu ^a   Kurooka, Hiroko ^a   Tamori, Akihiro ^a   Habu, Daiki ^a   Takeda, Tadashi ^a   Ochi, Hironobu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BLOOD CLOTTING FACTOR; MENATETRENONE; OSTEOCALCIN; URSODEOXYCHOLIC ACID; VITAMIN K GROUP;

ADULT; AGED; BILE SECRETION; BILIARY CIRRHOSIS; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; FRACTURE; HUMAN; INTESTINE ABSORPTION; LETTER; OSTEODYSTROPHY; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; RANDOMIZED CONTROLLED TRIAL;

FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; OSTEOPOROSIS; PILOT PROJECTS; VITAMIN K 2;

EID: 0034800681     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00133-7     Document Type: Letter

References (7)

1. Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dual-energy X-ray absorptiometry
2. Primary biliary cirrhosis
3. 2 (Menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
4. 1 level is decreased in primary biliary cirrhosis
5. Primary structure of the γ-carboxyglutamic acid-containing protein from bovine bone
6. 2 synthesis in vitro
7. Vitamin K